Do local hemodynamic alterations mediate injury in IgA nephropathy?
Woodroffe
A J
AJ
Renal Unit, Royal Adelaide Hospital, Australia.
Bannister
K M
KM
Bellon
M S
MS
Hale
G M
GM
Clarkson
A R
AR
D000804:Angiotensin II / Q000032:analysis; D002216:Captopril / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005919:Glomerular Filtration Rate; D005922:Glomerulonephritis, IGA / Q000188:drug therapy / Q000503:physiopathology*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000032:analysis; D007678:Kidney Glomerulus / Q000187:drug effects / Q000503:physiopathology*; D011897:Random Allocation; D011945:Receptors, Angiotensin / Q000032:analysis
D011945:Receptors, Angiotensin; D000804:Angiotensin II; D002216:Captopril